 | • レポートコード：GIR201106146 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、オレキシン受容体タイプ2の世界市場を調査対象にし、オレキシン受容体タイプ2の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（HTL-6641、MK-8133、Lemborexant、OPN-021、YNT-185、その他）、用途別分析（不眠症、ナルコレプシー、睡眠障害、大うつ病性障害）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Actelion Pharmaceuticals Ltd、OptiNose US Inc、Heptares Therapeutics Ltd、Eisai Co Ltd、Merck & Co Inc、Evotec AG、Johnson & Johnson、Idorsia Ltd、Yangtze River Pharmaceutical Group ・メーカー別販売量、売上、市場シェア ・オレキシン受容体タイプ2の地域別市場分析 ・オレキシン受容体タイプ2の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・オレキシン受容体タイプ2のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・オレキシン受容体タイプ2のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・オレキシン受容体タイプ2の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・オレキシン受容体タイプ2の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・オレキシン受容体タイプ2の種類別市場規模2015-2020：HTL-6641、MK-8133、Lemborexant、OPN-021、YNT-185、その他 ・オレキシン受容体タイプ2の用途別市場規模2015-2020：不眠症、ナルコレプシー、睡眠障害、大うつ病性障害 ・オレキシン受容体タイプ2の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Orexin Receptor Type 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Orexin Receptor Type 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Orexin Receptor Type 2 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Orexin Receptor Type 2 market has been segmented into
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others
By Application, Orexin Receptor Type 2 has been segmented into:
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Orexin Receptor Type 2 market presented in the report. This section sheds light on the sales growth of different regional and country-level Orexin Receptor Type 2 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Orexin Receptor Type 2 market.
The report offers in-depth assessment of the growth and other aspects of the Orexin Receptor Type 2 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Orexin Receptor Type 2 Market Share Analysis
Orexin Receptor Type 2 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Orexin Receptor Type 2 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Orexin Receptor Type 2 sales, revenue and market share for each player covered in this report.
The major players covered in Orexin Receptor Type 2 are:
Actelion Pharmaceuticals Ltd
OptiNose US Inc
Heptares Therapeutics Ltd
Eisai Co Ltd
Merck & Co Inc
Evotec AG
Johnson & Johnson
Idorsia Ltd
Yangtze River Pharmaceutical Group
Among other players domestic and global, Orexin Receptor Type 2 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orexin Receptor Type 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orexin Receptor Type 2, with price, sales, revenue and global market share of Orexin Receptor Type 2 in 2018 and 2019.
Chapter 3, the Orexin Receptor Type 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orexin Receptor Type 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Orexin Receptor Type 2 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Orexin Receptor Type 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Orexin Receptor Type 2 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orexin Receptor Type 2 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 HTL-6641
1.2.3 MK-8133
1.2.4 Lemborexant
1.2.5 OPN-021
1.2.6 YNT-185
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Orexin Receptor Type 2 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Insomnia
1.3.3 Narcolepsy
1.3.4 Sleep Disorders
1.3.5 Major Depressive Disorder
1.4 Overview of Global Orexin Receptor Type 2 Market
1.4.1 Global Orexin Receptor Type 2 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Actelion Pharmaceuticals Ltd
2.1.1 Actelion Pharmaceuticals Ltd Details
2.1.2 Actelion Pharmaceuticals Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Actelion Pharmaceuticals Ltd SWOT Analysis
2.1.4 Actelion Pharmaceuticals Ltd Product and Services
2.1.5 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 OptiNose US Inc
2.2.1 OptiNose US Inc Details
2.2.2 OptiNose US Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 OptiNose US Inc SWOT Analysis
2.2.4 OptiNose US Inc Product and Services
2.2.5 OptiNose US Inc Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Heptares Therapeutics Ltd
2.3.1 Heptares Therapeutics Ltd Details
2.3.2 Heptares Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Heptares Therapeutics Ltd SWOT Analysis
2.3.4 Heptares Therapeutics Ltd Product and Services
2.3.5 Heptares Therapeutics Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eisai Co Ltd
2.4.1 Eisai Co Ltd Details
2.4.2 Eisai Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eisai Co Ltd SWOT Analysis
2.4.4 Eisai Co Ltd Product and Services
2.4.5 Eisai Co Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck & Co Inc
2.5.1 Merck & Co Inc Details
2.5.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck & Co Inc SWOT Analysis
2.5.4 Merck & Co Inc Product and Services
2.5.5 Merck & Co Inc Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Evotec AG
2.6.1 Evotec AG Details
2.6.2 Evotec AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Evotec AG SWOT Analysis
2.6.4 Evotec AG Product and Services
2.6.5 Evotec AG Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Idorsia Ltd
2.8.1 Idorsia Ltd Details
2.8.2 Idorsia Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Idorsia Ltd SWOT Analysis
2.8.4 Idorsia Ltd Product and Services
2.8.5 Idorsia Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Yangtze River Pharmaceutical Group
2.9.1 Yangtze River Pharmaceutical Group Details
2.9.2 Yangtze River Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Yangtze River Pharmaceutical Group SWOT Analysis
2.9.4 Yangtze River Pharmaceutical Group Product and Services
2.9.5 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Orexin Receptor Type 2 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Orexin Receptor Type 2 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Orexin Receptor Type 2 Manufacturer Market Share in 2019
3.3.2 Top 6 Orexin Receptor Type 2 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Orexin Receptor Type 2 Sales, Revenue and Market Share by Regions
4.1.1 Global Orexin Receptor Type 2 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Orexin Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
4.2 North America Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.3 Europe Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.5 South America Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Orexin Receptor Type 2 Sales, Revenue and Market Share by Country
5.1.1 North America Orexin Receptor Type 2 Sales and Market Share by Country (2015-2020)
5.1.2 North America Orexin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
5.2 United States Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
5.3 Canada Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
5.4 Mexico Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Orexin Receptor Type 2 Sales, Revenue and Market Share by Country
6.1.1 Europe Orexin Receptor Type 2 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Orexin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
6.2 Germany Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.3 UK Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.4 France Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.5 Russia Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.6 Italy Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Orexin Receptor Type 2 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Orexin Receptor Type 2 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Orexin Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
7.2 China Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.3 Japan Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.4 Korea Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.5 India Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.7 Australia Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Orexin Receptor Type 2 Sales, Revenue and Market Share by Country
8.1.1 South America Orexin Receptor Type 2 Sales and Market Share by Country (2015-2020)
8.1.2 South America Orexin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
8.3 Argentina Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Orexin Receptor Type 2 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Orexin Receptor Type 2 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Orexin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
9.3 Turkey Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
9.4 Egypt Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
9.5 South Africa Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Orexin Receptor Type 2 Sales and Market Share by Type (2015-2020)
10.2 Global Orexin Receptor Type 2 Revenue and Market Share by Type (2015-2020)
10.3 Global Orexin Receptor Type 2 Price by Type (2015-2020)
11 Global Orexin Receptor Type 2 Market Segment by Application
11.1 Global Orexin Receptor Type 2 Sales Market Share by Application (2015-2020)
11.2 Global Orexin Receptor Type 2 Revenue Market Share by Application (2015-2020)
11.3 Global Orexin Receptor Type 2 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Orexin Receptor Type 2 Sales, Revenue and Growth Rate (2021-2025)
12.2 Orexin Receptor Type 2 Market Forecast by Regions (2021-2025)
12.2.1 North America Orexin Receptor Type 2 Market Forecast (2021-2025)
12.2.2 Europe Orexin Receptor Type 2 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Orexin Receptor Type 2 Market Forecast (2021-2025)
12.2.4 South America Orexin Receptor Type 2 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Orexin Receptor Type 2 Market Forecast (2021-2025)
12.3 Orexin Receptor Type 2 Market Forecast by Type (2021-2025)
12.3.1 Global Orexin Receptor Type 2 Sales Forecast by Type (2021-2025)
12.3.2 Global Orexin Receptor Type 2 Market Share Forecast by Type (2021-2025)
12.4 Orexin Receptor Type 2 Market Forecast by Application (2021-2025)
12.4.1 Global Orexin Receptor Type 2 Sales Forecast by Application (2021-2025)
12.4.2 Global Orexin Receptor Type 2 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Orexin Receptor Type 2 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Orexin Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Orexin Receptor Type 2 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Actelion Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Major Business
Table 9. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 10. Actelion Pharmaceuticals Ltd SWOT Analysis
Table 11. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product and Services
Table 12. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. OptiNose US Inc Basic Information, Manufacturing Base and Competitors
Table 14. OptiNose US Inc Orexin Receptor Type 2 Major Business
Table 15. OptiNose US Inc Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 16. OptiNose US Inc SWOT Analysis
Table 17. OptiNose US Inc Orexin Receptor Type 2 Product and Services
Table 18. OptiNose US Inc Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Heptares Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Heptares Therapeutics Ltd Orexin Receptor Type 2 Major Business
Table 21. Heptares Therapeutics Ltd Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 22. Heptares Therapeutics Ltd SWOT Analysis
Table 23. Heptares Therapeutics Ltd Orexin Receptor Type 2 Product and Services
Table 24. Heptares Therapeutics Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eisai Co Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Eisai Co Ltd Orexin Receptor Type 2 Major Business
Table 27. Eisai Co Ltd Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 28. Eisai Co Ltd SWOT Analysis
Table 29. Eisai Co Ltd Orexin Receptor Type 2 Product and Services
Table 30. Eisai Co Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 32. Merck & Co Inc Orexin Receptor Type 2 Major Business
Table 33. Merck & Co Inc Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 34. Merck & Co Inc SWOT Analysis
Table 35. Merck & Co Inc Orexin Receptor Type 2 Product and Services
Table 36. Merck & Co Inc Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Evotec AG Basic Information, Manufacturing Base and Competitors
Table 38. Evotec AG Orexin Receptor Type 2 Major Business
Table 39. Evotec AG Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 40. Evotec AG SWOT Analysis
Table 41. Evotec AG Orexin Receptor Type 2 Product and Services
Table 42. Evotec AG Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Orexin Receptor Type 2 Major Business
Table 45. Johnson & Johnson Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 46. Johnson & Johnson SWOT Analysis
Table 47. Johnson & Johnson Orexin Receptor Type 2 Product and Services
Table 48. Johnson & Johnson Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Idorsia Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Idorsia Ltd Orexin Receptor Type 2 Major Business
Table 51. Idorsia Ltd Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 52. Idorsia Ltd SWOT Analysis
Table 53. Idorsia Ltd Orexin Receptor Type 2 Product and Services
Table 54. Idorsia Ltd Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Yangtze River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 56. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Major Business
Table 57. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 58. Yangtze River Pharmaceutical Group SWOT Analysis
Table 59. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product and Services
Table 60. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Orexin Receptor Type 2 Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global Orexin Receptor Type 2 Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Orexin Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 64. Global Orexin Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 65. Global Orexin Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Orexin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 67. North America Orexin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 68. North America Orexin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Orexin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 70. Europe Orexin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe Orexin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 72. Europe Orexin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Orexin Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific Orexin Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Orexin Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Orexin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 77. South America Orexin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 78. South America Orexin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Orexin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Orexin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa Orexin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Orexin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Orexin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 84. Global Orexin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 85. Global Orexin Receptor Type 2 Sales Share by Type (2015-2020)
Table 86. Global Orexin Receptor Type 2 Revenue by Type (2015-2020) (USD Million)
Table 87. Global Orexin Receptor Type 2 Revenue Share by Type (2015-2020)
Table 88. Global Orexin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 89. Global Orexin Receptor Type 2 Sales Share by Application (2015-2020)
Table 90. Global Orexin Receptor Type 2 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global Orexin Receptor Type 2 Market Share Forecast by Regions (2021-2025)
Table 92. Global Orexin Receptor Type 2 Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global Orexin Receptor Type 2 Market Share Forecast by Type (2021-2025)
Table 94. Global Orexin Receptor Type 2 Sales Forecast by Application (2021-2025)
Table 95. Global Orexin Receptor Type 2 Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Orexin Receptor Type 2 Picture
Figure 2. Global Sales Market Share of Orexin Receptor Type 2 by Type in 2019
Figure 3. HTL-6641 Picture
Figure 4. MK-8133 Picture
Figure 5. Lemborexant Picture
Figure 6. OPN-021 Picture
Figure 7. YNT-185 Picture
Figure 8. Others Picture
Figure 9. Orexin Receptor Type 2 Sales Market Share by Application in 2018
Figure 10. Insomnia Picture
Figure 11. Narcolepsy Picture
Figure 12. Sleep Disorders Picture
Figure 13. Major Depressive Disorder Picture
Figure 14. Global Orexin Receptor Type 2 Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Orexin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Orexin Receptor Type 2 Sales Market Share by Manufacturer in 2019
Figure 35. Global Orexin Receptor Type 2 Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Orexin Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Orexin Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Orexin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Orexin Receptor Type 2 Revenue Market Share by Regions (2015-2020)
Figure 42. Global Orexin Receptor Type 2 Revenue Market Share by Regions in 2018
Figure 43. North America Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 44. Europe Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 46. South America Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Orexin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 48. North America Orexin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Orexin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Figure 50. North America Orexin Receptor Type 2 Sales Market Share by Countries in 2018
Figure 51. North America Orexin Receptor Type 2 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Orexin Receptor Type 2 Revenue Market Share by Countries in 2018
Figure 53. United States Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Orexin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Orexin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Orexin Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 59. Germany Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Orexin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Orexin Receptor Type 2 Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Orexin Receptor Type 2 Revenue Market Share by Regions 2019
Figure 67. China Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Orexin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Orexin Receptor Type 2 Sales Market Share by Countries in 2019
Figure 74. South America Orexin Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 75. Brazil Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Orexin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Orexin Receptor Type 2 Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Orexin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Orexin Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Orexin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Orexin Receptor Type 2 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Orexin Receptor Type 2 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Orexin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Orexin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Orexin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Orexin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Orexin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
アルファ2Cアドレナリン受容体の世界市場 2020年 Market Overview The global Alpha 2C Adrenergic Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha 2C Adrener…- ソマトスタチン受容体4型の世界市場 2020年 Market Overview The global Somatostatin Receptor Type 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Rec…
- ソマトスタチン受容体2型の世界市場 2020年 Market Overview The global Somatostatin Receptor Type 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Rec…
- レチノイン酸受容体ベータの世界市場 2020年 Market Overview The global Retinoic Acid Receptor Beta market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinoic Acid Rec…
- 5-ヒドロキシトリプタミン受容体7の世界市場 2020年 Market Overview The global 5-Hydroxytryptamine Receptor 7 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The 5-Hydroxytrypt…